This lack of losartan-associated effects on the TGFβ signalling pathway in OI fibroblasts was confirmed by the failure to inhibit SMAD2 phosphorylation 72 h following exposure to 5uM losartan (supplementary Fig. 4b). This evidence concerns the gene SMAD2 and osteogenesis imperfecta.